Poster: AML-162: Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Updated Analyses of a Phase 1b Study

Authors :: Jessica K. Altman
Naval Daver
Joseph Maly
Mark Levis
Ellen Ritchie
Mark Litzow
James McCloskey
Catherine C. Smith
Gary Schiller
Terrence Bradley
Ramon V. Tiu
Kiran Naqvi
Satya Siddani
Jing Wang
Paul Lee
Alexander E. Perl
Source :: Clinical Lymphoma Myeloma and Leukemia. 21:S212
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Full Text Access

Tools